RPh Innovations Competitors and Similar CompaniesClear all

RPh Innovations's competitors and similar companies include Y.S.P. SOUTHEAST ASIA HOLDING, Bioforum, Shandong Buchang Pharmaceuticals and Corona Remedies.

	RPh Innovations RPh Innovations (RPHI) is a provider of 340B program management and pharmacy-related support solutions to rural primary care organizations.	Y.S.P. SOUTHEAST ASIA HOLDING Y.S.P. Southeast Asia Holding is a company that manufactures pharmaceutical products.	Bioforum Bioforum is a provider of healthcare services.	Shandong Buchang Pharmaceuticals Shandong Buchang Pharmaceuticals (山东步长制药股份有限公司) is a company that specializes in medicine and pharmacy.	Corona Remedies Corona Remedies is a pharmaceutical company that manufactures tablets, capsules, syrups, ointments, gum paints, and injectables.
Founding Date	Founding Date 2011	Founding Date 1987	Founding Date 1998	Founding Date 1993	Founding Date N/A
Type	Type Private	Type Public	Type Private	Type Public	Type Private
Tags	Tags Healthcare augmented reality data management pharma pharmacy	Tags Healthcare pharma pharmacy	Tags Healthcare data management pharma pharmacy	Tags Healthcare pharma pharmacy	Tags Healthcare pharma pharmacy
Locations	Locations Downers Grove, US HQ	Locations Kuala Lumpur, MY HQ	Locations Ness Ziona, IL HQ	Locations Xi'an, CN HQ	Locations Ahmedabad, IN HQ Bavla, IN Bhayla, IN
Employees	Employees 3	Employees 1,380	Employees 1761% increase	Employees 7,689	Employees 1,8091% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) RM365.1m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ¥11.7b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods RM172.4m (FY, 2025)	Cost of goods N/A	Cost of goods ¥4.4b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit RM196.7m (FY, 2025)	Gross profit N/A	Gross profit ¥7.3b (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income RM25.2m (FY, 2025)	Net income N/A	Net income ¥192.3m (FY, 2025)	Net income N/A